Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1 Lupus Erythematosus, Systemic 1 Infections 1

Interventions

pembrolizumab 39 Bevacizumab 25 Cyclophosphamide 23 Blood Specimen Collection 19 Standard of Care 17 Nivolumab 17 Carboplatin 17 Paclitaxel 15 Exercise 15 Gemcitabine 14 atezolizumab 13 Pemetrexed 13 Cisplatin 13 Radiotherapy 11 Fluorouracil 11 Doxorubicin 11 Cetuximab 10 130-nm albumin-bound paclitaxel 10 durvalumab 9 Rituximab 9 Oxaliplatin 9 Magnetic Resonance Spectroscopy 9 Leucovorin 9 Docetaxel 9 Biopsy 9 abemaciclib 8 Temozolomide 8 Surveys and Questionnaires 8 Prednisone 8 olaparib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × anifrolumab × 90 days × Clear all

NCT07000110 2026-05-20

SIMA

AstraZeneca

Infections, Lupus Erythematosus, Systemic, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡